There are many amazing pop culture stories of lone wolf heroes who, relying only on their individual skills, vision and pluck, embark on great journeys, emerging victorious, proof of the power of the human spirit.
Like nothing else, COVID-19 has put once-simple choices in stark contrast.
Though there's a new year on the calendar, we're still living much of the same ole existence since the pandemic's grip set in. And it's brought once-answered questions back to the fore.
Among the treatment options your doctor can offer, nobody wants the silent treatment.
That's what happens when the promise — and expectation — of connected care via telehealth goes unfulfilled. It's a letdown that can be life-threatening for the millions living with heart arrythmias.
Abbott Announces it's Pandemic Defense Coalition: A Global Network of Expert Collaborators Designed to Help Prevent Future Pandemics, Currently Searching for COVID-19 Variants
Abbott is intently monitoring the mutations of COVID so we can ensure our tests can detect them, as we do with many viruses. We have conducted a thorough analysis of the new variants, and we are confident that our tests remain effective at detecting these strains.
We're working across our business and in partnership with others to help more people get the care they need.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the findings of its 6th annual sleep survey in a report titled Seeking Solutions: How COVID-19 Changed Sleep Around the World.